|
Post by cretin11 on Sept 10, 2021 10:21:19 GMT -5
The partnership with UTHR gave MannKind much needed up front cash and milestone payments. It also gave a legitimate endorsement for the platform moving forward with a reputable company. Oh yeah, and those royalties that everyone is projecting to come in nicely. If these were not in place, MannKind would be hemorrhaging money with completely stagnant Afrezza sales and like casualinvestor said, management would just be in a perpetual cycle of trying to raise funds at crappy rates. Management's ability to restructure the financials leaned heavily on the prospects stemming from the partnership as well. So we can absolutely say the partnership saved investors from being gutted into the ground. Well said, and that factual perspective shouldn’t hurt anyone’s feelings. And getting this back to the original thread topic, it is legitimate for some of us true longs to be concerned about still needing Wainwright, and hoping this will be the last time.
|
|
|
Post by sportsrancho on Sept 10, 2021 10:24:31 GMT -5
Yep we need to move up in the world along with pps
|
|
|
Post by cedafuntennis on Sept 10, 2021 11:26:22 GMT -5
I think, or more accurately, I hope that Wainwright's role in this is more geared towards the big investors, mutual funds and exposure in genre. As long as MNKD canned the sale/lease of the factory, I think the need for cash is off the map.
|
|
|
Post by goyocafe on Sept 10, 2021 12:16:51 GMT -5
The partnership with UTHR gave MannKind much needed up front cash and milestone payments. It also gave a legitimate endorsement for the platform moving forward with a reputable company. Oh yeah, and those royalties that everyone is projecting to come in nicely. If these were not in place, MannKind would be hemorrhaging money with completely stagnant Afrezza sales and like casualinvestor said, management would just be in a perpetual cycle of trying to raise funds at crappy rates. Management's ability to restructure the financials leaned heavily on the prospects stemming from the partnership as well. So we can absolutely say the partnership saved investors from being gutted into the ground. Just drawn, but not quartered.
|
|
|
Post by sportsrancho on Sept 10, 2021 13:51:51 GMT -5
“Small-cap stock analyst... If their mouths are moving, they are likely lying to you. You are nothing but prey to them. They see you as a sucker to be fleeced. Their primary function is to facilitate the transfer of money from your account into their own accounts and/or the accounts of the companies for whom they raise capital. Never trust them nor their pie-in-the-sky price targets. It's all BS. Names you cannot trust include: Rodman & Crenshaw, H.C. Wainwright, Leerink, Cowen, Zacks, and many more. Below is just a small sampling of some of their dirty deeds:” www.lqqkerinsider.com/rules-of-the-road.html
|
|
|
Post by akemp3000 on Sept 10, 2021 16:44:51 GMT -5
The partnership with UTHR gave MannKind much needed up front cash and milestone payments. It also gave a legitimate endorsement for the platform moving forward with a reputable company. Oh yeah, and those royalties that everyone is projecting to come in nicely. If these were not in place, MannKind would be hemorrhaging money with completely stagnant Afrezza sales and like casualinvestor said, management would just be in a perpetual cycle of trying to raise funds at crappy rates. Management's ability to restructure the financials leaned heavily on the prospects stemming from the partnership as well. So we can absolutely say the partnership saved investors from being gutted into the ground. The chain of events are certainly facts and it can be speculated that the UTHR partnership saved investors but not with absolute certainty. It could also be speculated that management may have been in talks with several other significant players at the time offering other opportunities that were ultimately deemed less attractive and Mannkind chose to go all in with the UTHR relationship. There is no basis to know with certainty that these speculations are factual. IMO, management has very strong resumes so having a plan B and C throughout would seem logical. It certainly didn't feel that way at the time because retail investors were all out in the cold without knowledge of what was happening behind the curtain but I've never doubted the superior science would eventually win out. This is of course speculation because we've never known the path. We do now
|
|
|
Post by cretin11 on Sept 10, 2021 19:29:36 GMT -5
akemp, agreed it’s all speculation. But seems illogical that MNKD chose the UTHR partnership over a slew of other potentially good opportunities, any of which also could’ve bailed us out and saved investors from severe distress. Here’s why I say that:
Because if there were multiple opportunities that were so compelling, it would’ve been malfeasance for the company NOT to pursue those, even while also saying yes to UTHR. The whole point of TS is that we can have multiple tracks, certainly not having to go all in on any one of them.
For that reason, pretty high confidence in what awesomo stated, that the UTHR deal saved our bacon. And that’s fine, we will surely take it. But anyone who says “thank you Martine!” has valid basis for saying it. And we do need more good collaborations that produce revenue if we’re ever going to reach the potential we believed we were investing in. After all, veins of gold, embarrassment of riches, and all that jazz…
|
|
|
Post by akemp3000 on Sept 11, 2021 6:13:26 GMT -5
There's no malfeasance if a small biotech recognizes they don't have the financial or personnel horsepower to pursue more than one big opportunity at a time. Again, just speculating.
|
|
|
Post by cretin11 on Sept 11, 2021 6:47:03 GMT -5
We have several tracks already. Only one of them produces revenue, with another hopefully soon. If a strong revenue producing opportunity were available, I hope we are pursuing it, even if it means jettisoning one of the lesser hopeful ones.
People mocked the “veins of gold” and “embarrassment of riches” comments in hindsight, but some of us remember when we actually lauded those comments as celebratory and accurate. Then fast forward a couple of years and we also remember when Hakan openly begged for potential collaborators to please call him. So no, I don’t think it’s likely we’ve been turning away good potential deals, and hopefully we won’t do that but will rather add them to our TS stable whenever possible.
|
|
|
Post by hellodolly on Sept 11, 2021 7:02:57 GMT -5
While it's all speculation, that offers were made that could have bailed out MNKD and shareholders before UTHR came along, I simply look at the offer we got from UTHR and hold that up as the barometer of what MC was looking for. If there were offers that were better, which are highly unlikely or MC would have taken them based on the barometer, he would have. Why wouldn't Mike take up an offer like UTHR's if we had them...it's because we didn't have offers as good or better. I agree with cretin11 it's illogical that MNKD would pass over opportunities just as good or better than UTHR.
|
|
|
Post by prcgorman2 on Sept 11, 2021 7:13:03 GMT -5
I guess my fundamental feeling is no matter all the complaining everytime MNKD participates in any “conference” hosted by financing and analytics companies, there has been a positive result either in terms of much needed operating capital (often on awful terms because, well yeah, beggars couldn’t be choosers) but more importantly in the last year or so the increase in institutional ownership of MNKD shares. Just like the UTHR partnership, that increase in institutional ownership is not charity. The increase in institutional ownership through conferences like Wainright’s provides direct evidence of growing confidence on the Street about Mannkind’s prospects.
|
|
|
Post by sportsrancho on Sept 11, 2021 9:16:32 GMT -5
Being invested in other companies I see how the CEOs do it ..they’re upfront with their shareholders when they need to raise money way ahead of time, they explain that’s it is for exceptional growth in the future, they tell you what that growth is for and they give guidance or projections about what that growth could be. They unite the shareholders so when they do raise money the shares of bought right back up.
Not saying that’s what’s going to happen at all, but I just have noticed such a big difference in companies and how they go about their leadership.
|
|
|
Post by mannmade on Sept 11, 2021 10:11:22 GMT -5
I think when Mike first came on as CEO, one of his first statements and promises was for more transparency. You be the judge... GLTAL's!!!
|
|
|
Post by awesomo on Sept 11, 2021 10:24:40 GMT -5
For all those claiming Mike had to choose from all these great partnership offers, just take a look at the list of “partnerships” that he did sign and have amounted to next to nothing so far. No up front cash, no milestone payments, no updated developments, absolute crickets.
Tanner, Thirona, Immix, AMSL Diabetes, etc.
|
|
|
Post by mango on Sept 11, 2021 12:49:51 GMT -5
For all those claiming Mike had to choose from all these great partnership offers, just take a look at the list of “partnerships” that he did sign and have amounted to next to nothing so far. No up front cash, no milestone payments, no updated developments, absolute crickets. Tanner, Thirona, Immix, AMSL Diabetes, etc. I mean, I get what you’re saying and don’t completely disagree. However, some of these partnerships were never meant to bring huge return, such as was the case with Tanner. Thirona we’re are developing a new chemical entity with, that’s been confirmed and even highlighted in presentations by MC. Immix appears to have been a bust for sure. You did leave out Qrum which we acquired and have a drug from that acquisition entering Phase 1 clinical trials this 4Q. And then we have the most recent partnership with NRx which I believe will become successful, but only time will tell. This one is much too soon to call a bust as it takes time to formulate a successful product.
|
|